Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease-Reference-Cited by-同舟云学术

Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease

Published:2010-01 Issue:1 Volume:18 Page:44-53
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Hudry Eloise,Van Dam Debby,Kulik Wim,De Deyn Peter P,Stet Femke S,Ahouansou Ornella,Benraiss Abdellatif,Delacourte André,Bougnères Pierre,Aubourg Patrick,Cartier Nathalie

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. The synaptic Abeta hypothesis of Alzheimer disease;Tanzi;Nat Neurosci,2005

2. Regulation of APP cleavage by alpha-, beta- and gamma-secretases;Nunan;FEBS Lett,2000

3. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease;Strittmatter;Proc Natl Acad Sci USA,1993

4. Alzheimer's disease: the cholesterol connection;Puglielli;Nat Neurosci,2003

5. Cholesterol and the biology of Alzheimer's disease;Wolozin;Neuron,2004

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier;Ageing Research Reviews;2024-11

2. Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics;ACS Pharmacology & Translational Science;2024-09-06

3. Cholesterol Metabolism in Neurodegenerative Diseases;Antioxidants & Redox Signaling;2024-07-11

4. The cholesterol 24-hydroxylase enzyme, CYP46A1, reduces overexpressed alpha-synuclein proteins in human cellular models of Parkinson’s disease.;2024-07-03

5. Modulation of Brain Cholesterol Metabolism through CYP46A1 Overexpression for Rett Syndrome;Pharmaceutics;2024-06-03